Edition:
United States

CASI Pharmaceuticals Inc (CASI.OQ)

CASI.OQ on NASDAQ Stock Exchange Capital Market

3.73USD
3:59pm EST
Change (% chg)

$-0.05 (-1.32%)
Prev Close
$3.78
Open
$3.77
Day's High
$3.87
Day's Low
$3.66
Volume
15,910
Avg. Vol
169,954
52-wk High
$4.83
52-wk Low
$0.91

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.027
Jun '17 0.00 -0.040
Mar '17 0.00 -0.028
FY 2016 Dec '16 0.00 -0.029
Sep '16 0.00 -0.034
Jun '16 0.00 -0.077
Mar '16 0.00 -0.045
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.40 0.40 0.40 0.00
Earnings (per share)
Quarter Ending Mar-18 1 -0.02 -0.02 -0.02 --
Quarter Ending Jun-18 1 -0.02 -0.02 -0.02 --
Year Ending Dec-18 1 -0.10 -0.10 -0.10 -0.24
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 187.16 35.64
P/E High - Last 5 Yrs. -- 283.01 46.80
P/E Low - Last 5 Yrs. -- 92.63 24.18
Beta 0.82 0.81 0.81
Price to Sales (TTM) -- 144.25 8.67
Price to Book (MRQ) 14.61 19.79 5.21
Price to Tangible Book (MRQ) 15.79 26.40 6.35
Price to Cash Flow (TTM) -- 124.99 26.03
% Owned Institutions 15.23 11.86 2.27

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.51
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.92 5.24
Payout Ratio(TTM) -- 8.43 44.74

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 19.88 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 61.01 7.55
Sales - 5 Yr. Growth Rate -- 32.71 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 22.09 -97.85 16.86
EPS (TTM) vs TTM 1 Yr. Ago 40.25 -- --
EPS - 5 Yr. Growth Rate -- 46.54 11.51
Capital Spending - 5 Yr. Growth Rate 106.12 42.29 14.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.42
Current Ratio (MRQ) 7.35 5.73 3.38
LT Debt to Equity (MRQ) 0.00 16.72 12.01
Total Debt to Equity (MRQ) 9.61 18.87 15.38
Interest Coverage (TTM) -324.12 -164.25 39.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.19 54.84
Gross Margin - 5 Yr. Avg. -- 55.55 52.61
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -7,125.71 -566.09 9.77
Operating Margin (TTM) -- -598.23 2.53
Operating Margin - 5 Yr. Avg. -7,155.52 -587.15 5.00
Pre-Tax Margin (TTM) -- -568.90 3.34
Pre-Tax Margin - 5 Yr. Avg. -8,524.58 -595.33 5.26
Net Profit Margin (TTM) -- -564.05 -0.18
Net Profit Margin - 5 Yr. Avg. -8,524.58 -599.22 1.54
Effective Tax Rate (TTM) -- 0.16 22.12
Effective Tax Rate - 5 Yr. Avg. -- 17.90 24.22

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,686,315 822,216,427
Net Income/Employee (TTM) -- -650,139 96,151,835
Receivable Turnover (TTM) -- 14.03 5.40
Inventory Turnover (TTM) -- 2.43 3.51
Asset Turnover (TTM) 0.00 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -35.37 -1.09 10.70
Return on Assets - 5 Yr. Avg. -110.60 -0.33 12.00
Return on Investment (TTM) -40.07 -0.71 13.57
Return on Investment - 5 Yr. Avg. -119.58 2.30 15.72
Return on Equity (TTM) -53.14 -3.52 15.19
Return on Equity - 5 Yr. Avg. -238.20 -1.79 16.94
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % 23.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CASI Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 15.23%
# of Holders: 46
Total Shares Held: 9,912,619
3 Mo. Net Change: 1,251,090
# New Positions: 14
# Closed Positions: 3
# Increased Positions: 24
# Reduced Positions: 10
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.